by Randall E. Harris (Author)
Organized into five sections, the text begins with an introductory chapter which examines the new public health environment in which chronic diseases have replaced acute infectious conditions concurrent with improved health care and increasing longevity in many populations of the world.
Subsequent sections cover cardiovascular and cerebrovascular diseases, major forms of cancer, diseases of the respiratory tract, metabolic and digestive diseases, musculoskeletal diseases, neurodegenerative diseases, and finally, three infectious diseases that often manifest as chronic conditions.
Special sections in each chapter focus on controversial topics that can serve as a launching point for classroom discussion of molecular mechanisms of disease pathogenesis and the relevant epidemiologic issues pertaining to the prevention and control of chronic diseases.
Key Features:
– Special sections in each chapter focus on controversial topics that can serve as a launching point for classroom discussion of molecular mechanisms of disease pathogenesis and the relevant epidemiologic issues pertaining to the prevention and control of chronic diseases.
– Four new chapters on the epidemiology of congestive heart failure, peripheral artery disease and aortic dissection, venous thromboembolism and pulmonary embolism, and sudden cardiac death.
– Discussion of new findings, such as the association of post-traumatic stress disorder (PTSD) with suicide and the emerging crisis of antibiotic resistance in tuberculosis and other chronic infections.
– Updated epidemiologic findings and references throughout.
– Robust instructor’s materials, including an online instructor’s manual with recommended questions and answers for each chapter, slides in PowerPoint format, and a test bank.
Product Details
- Paperback: 938 pages
- Publisher: Jones & Bartlett Learning; 2 edition (April 25, 2019)
- Language: English
- ISBN-10: 1284151018
- ISBN-13: 978-1284151015
- Product Dimensions: 21.4 x 2 x 10.8 inches
Reviews
There are no reviews yet.